Lipocine
LPCN
LPCN
46 hedge funds and large institutions have $4.85M invested in Lipocine in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
49% less capital invested
Capital invested by funds: $9.54M → $4.85M (-$4.69M)
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Holders
46
Holding in Top 10
–
Calls
$496K
Puts
$16K
Top Buyers
| 1 | +$133K | |
| 2 | +$53.4K | |
| 3 | +$42K | |
| 4 |
EWA
EP Wealth Advisors
Torrance,
California
|
+$12K |
| 5 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
+$7K |
Top Sellers
| 1 | -$353K | |
| 2 | -$119K | |
| 3 | -$71.1K | |
| 4 |
Mercer Global Advisors
Denver,
Colorado
|
-$67.9K |
| 5 |
B
Bailard
Foster City,
California
|
-$60K |